BERGER; Sven
Patent Applications and Registrations
Patent applications and USPTO patent grants for BERGER; Sven.The latest application filed is for "novel fusion polypeptide specific for lag-3 and pd-1".
- BERGER; Sven - Munich DE
- BERGER; Sven - Poisy FR
- Berger; Sven - Haute-Savoie FR
| Patent | Date |
|---|---|
| Novel Fusion Polypeptide Specific For Lag-3 And Pd-1 App 20190010231 - ROTHE; Christine ; et al. | 2019-01-10 |
| Novel Humanized Adam17 Antibody App 20180057601 - LOWE; Peter ; et al. | 2018-03-01 |
| Methods and antibodies for treating cancer Grant 9,540,450 - Van De Winkel , et al. January 10, 2 | 2017-01-10 |
| Novel Methods And Antibodies For Treating Cancer App 20140348833 - VAN DE WINKEL; Jan ; et al. | 2014-11-27 |
| Phage display vector Grant 8,728,983 - Lowe , et al. May 20, 2 | 2014-05-20 |
| Novel Phage Display Vector App 20120322678 - Lowe; Peter ; et al. | 2012-12-20 |
| Novel Methods And Antibodies For Treating Cancer App 20110256142 - Van De Winkel; Jan ; et al. | 2011-10-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 